BIOMAT Database Logo BIOMAT Database Logo

[Markers of hepatitis B virus in blood donors]. 1985

T V Golosova, and M Kselikova, and A N Margolina, and I Urbankova, and I N Pobedinskaia

UI MeSH Term Description Entries
D009031 Moscow The capital of Russia.
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D003604 Czechoslovakia Created as a republic in 1918 by Czechs and Slovaks from territories formerly part of the Austro-Hungarian Empire. The country split into the Czech Republic and Slovakia 1 January 1993.
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006511 Hepatitis B Antigens Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS. HBAg,Hepatitis B Antigen,Antigen, Hepatitis B,Antigens, Hepatitis B,B Antigen, Hepatitis,B Antigens, Hepatitis
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T V Golosova, and M Kselikova, and A N Margolina, and I Urbankova, and I N Pobedinskaia
Hepatitis B virus markers in male saudi blood donors.
January 1986, Annals of Saudi medicine,
T V Golosova, and M Kselikova, and A N Margolina, and I Urbankova, and I N Pobedinskaia
Prediction of occult hepatitis B virus infection in liver transplant donors through hepatitis B virus blood markers.
November 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver,
T V Golosova, and M Kselikova, and A N Margolina, and I Urbankova, and I N Pobedinskaia
Hepatitis B virus markers in blood donors in the west of Scotland.
October 1981, Medical laboratory sciences,
T V Golosova, and M Kselikova, and A N Margolina, and I Urbankova, and I N Pobedinskaia
Prevalence of hepatitis D virus in blood donors with different hepatitis B virus markers of infection.
September 2021, European journal of gastroenterology & hepatology,
T V Golosova, and M Kselikova, and A N Margolina, and I Urbankova, and I N Pobedinskaia
[Retrovirus, hepatitis B and C virus markers in milk and blood donors].
January 1995, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
T V Golosova, and M Kselikova, and A N Margolina, and I Urbankova, and I N Pobedinskaia
[Hepatitis B-associated serological markers in blood donors].
March 1984, Gematologiia i transfuziologiia,
T V Golosova, and M Kselikova, and A N Margolina, and I Urbankova, and I N Pobedinskaia
[Immunological markers of hepatitis B virus in the population of Polish blood donors].
January 1983, Acta haematologica Polonica,
T V Golosova, and M Kselikova, and A N Margolina, and I Urbankova, and I N Pobedinskaia
Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors.
April 2014, BMC infectious diseases,
T V Golosova, and M Kselikova, and A N Margolina, and I Urbankova, and I N Pobedinskaia
Hepatitis-B virus markers in patients with bleeding disorders and in healthy blood donors.
January 1978, Transfusion,
T V Golosova, and M Kselikova, and A N Margolina, and I Urbankova, and I N Pobedinskaia
Unusual hepatitis B virus findings in blood donors.
July 2023, The Medical journal of Australia,
Copied contents to your clipboard!